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Biochemical Association of CD45 with the T Cell
Receptor Complex: Regulation by CD45 Isoform
and during T Cell Activation
corrected upon reconstitution with CD45 (Trowbridge
and Thomas, 1994), it is likely that the predominant sub-
strates of CD45 in vivo would be involved in enhancing
TCR signaling cascades upon dephosphorylation. Sub-
strates that fulfill this requirement are the src family
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New Haven, Connecticut 06510 kinases lck and fyn, which are negatively regulated by
phosphorylation of the tyrosine at the carboxyl terminus.
Dephosphorylation at this site causes an increase in
kinase activity and frees the SH2 domain to interactSummary
with other signaling molecules. CD45 regulation of lck
phosphorylation in vivo is supported by a number ofCD45 is the predominant transmembrane tyrosine
phosphatase in lymphocytes and is required for the independent studies demonstrating CD45 association
with lck (Schraven et al., 1991; Guttinger et al., 1992;efficient induction of T cell receptor signaling and acti-
vation. However, the regulation of CD45 activity and Koretzky et al., 1993), increased basal tyrosine phos-
phorylation of lck at the regulatory carboxy-terminal ty-substrate specificity are poorly understood. In the
present study, we demonstrate a basal biochemical rosine in CD45-negative cells (Ostergaard et al., 1989;
Burns et al., 1994), and decreased lck kinase activity inassociation of CD45 with the T cell receptor complex
that is regulated in part by CD45 isoform expression. a CD45-negative antigen-dependent T cell cloned line
(McFarland et al., 1993). In addition, cells transfectedFurther, maintenance of CD45/TCR association is dif-
ferentially regulated following TCR ligation with pep- with a constitutively active EGF-lck chimera were able
to reconstitute TCR signaling in a CD45-negative celltide: a partial agonist peptide induces CD45/TCR dis-
sociation while an agonist peptide promotes sustained line (Duplay et al., 1996). The regulation of lck kinase
activity by CD45 in vivo appears complex, however,association in a CD4-dependent manner. These data
suggest that T cell receptor signaling pathways may since there are several examples of CD45-negative T
cells that actually have unchanged or increased lck ki-be modulated by altering access of CD45 to TCR-
associated substrates involved in T cell activation. nase activity (Ostergaard et al., 1989; Burns et al., 1994)
apparently due to dephosphorylation of a positive regu-
latory tyrosine at position 394 (D'Oro et al., 1996). Thus,Introduction
although it is clear that lck is a substrate for CD45 that
can enhance T cell signaling, it is uncertain if this isThe transmembrane tyrosine phosphatase CD45 is com-
directly related to lck kinase activity rather than CD45posed of a large heavily glycosylated extracellular por-
maintaining lck in an ªopenº configuration that enablestion, which can exist as at least eight different isoforms
interaction of the SH2 domain of lck with other phospho-generated by alternative RNA splicing of exons encod-
tyrosine-containing molecules (Sieh et al., 1993). Re-ing the ectodomain, and a cytoplasmic portion with pro-
gardless of the precise mechanism by which CD45 regu-tein tyrosine phosphatase activity, which is required to
lates TCR signal transduction, it is likely that regulationgenerate efficient TCR signal transduction (reviewed in
of the associations of CD45 with molecules involved inTrowbridge and Thomas, 1994). In CD41 T lymphocytes,
TCR signaling will have an impact on CD45 activity.the expression of different isoforms of CD45 is regulated
We hypothesized that different ectodomain isoformsduring thymic development (Lefrancois and Goodman,
of CD45 may regulate substrate access to the tyrosine1987; Hathcock et al., 1992), as well as during the gener-
phosphatase domains by targeting CD45 to distinct ar-ation and maturation of an immune response in the pe-
eas in the membrane where it can associate with otherriphery (Akbar et al., 1988; Bottomly et al., 1989; Lee et
molecules important in T cell signal transduction, alter-al., 1990) and in different effector cell subsets (Luqman
ing their phosphorylation status and modifying the TCRet al., 1991; Rogers et al., 1992). The regulated pattern
signal transduction pathway. In support of this hypothe-of CD45 isoform expression suggests that the ectodo-
sis, we and others have utilized CD45-negative T linesmain of CD45 may influence the activity of the cyto-
transfected with individual isoforms of CD45 and shownplasmic phosphatase domains.
that cells that express the low molecular weight isoformsIn vitro studies have identified several potential sub-
(e.g., CD45Null, aka CD45RO) of CD45 are more sensi-strates for the CD45 tyrosine phosphatase that are in-
tive to T cell receptor signaling than cells that expressvolved in the signaling cascade following T cell receptor
high molecular weight CD45 isoforms (e.g., CD45ABC)ligation, including the src family tyrosine kinases lck and
as measured by IL-2 production (Novak et al., 1994;fyn, as well as TCR z chains and the ZAP 70 tyrosine
McKenney et al., 1995; Leitenberg et al., 1996). We havekinase (Mustelin et al., 1989, 1992, 1995; Furukawa et
further shown that the increased responsiveness to anti-al., 1994). Since T cells from CD45-deficient mice and
gen signaling correlates with the ability of individual lowCD45-negative T cell lines demonstrate profoundly im-
molecular weight CD45 isoforms to associate with thepaired T cell activation and development that can be
CD4/T cell receptor complex compared to cells express-
ing high molecular weight isoforms (CD45ABC) in fluo-³ To whom correspondence should be addressed (e-mail: kim.
bottomly@yale.edu). rescence colocalization studies (Leitenberg et al., 1996).
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Figure 1. Low Molecular Weight CD45 Iso-
form-Specific Association with the CD4/T Cell
Receptor Complex Is Independent of CD4
CD4 or TCR was induced to cap on BW cells
transfected with CD45RO using biotinylated
antibodies and an avidin-phycoerythrin con-
jugate. Association with CD45 was detected
using fluorescein-labeled anti-CD45. Dual-
color fluorescent analysis was done using the
ACAS 570 video laser cyometer. (A) indicates
representative pseudocolor images of capped
and cocapped cells with gradations in color
indicating changes in fluorescent intensity.
The arrows indicate the regions on the cell
where capping occurred. (B) represents an
average and standard deviation of the fluo-
rescent colocalization data in three indepen-
dent experiments in which CD3/TCR or CD4
was induced to cap in cells bearing CD45RO
or CD45ABC. In each experiment, a minimum
of 100 capped cells were counted, and the
percent of cells with CD45 colocalization was
determined.
However, it was unclear from the fluorescent localiza- of this hypothesis, the regulation of CD45/TCR associa-
tion following stimulation with specific antigen was al-tion experiments whether the association of the CD4/
TCR complex with CD45 was primarily dependent on tered depending on the potency of the TCR ligand. These
experiments utilized a previously described model systemthe TCR or CD4 since cap induction with anti-TCR or
anti-CD4 antibodies causes visible association of both in which transgenic CD41 T cells specific for a peptide
of moth cytochrome C (MCC) were stimulated with anCD3 and CD4 in addition to CD45 in a trimolecular com-
plex of all three molecules. Furthermore, it was unclear agonist peptide or a variant peptide that acts as a partial
agonist (Boutin et al., 1997; Tao et al., 1997). Interest-if CD45 association with the CD4/TCR complex was
dependent on cell activation that may be a byproduct ingly, when cells were stimulated with antigen-present-
ing cells (APCs) pulsed with the variant peptide, theof cap induction or if there is a basal association of low
molecular weight CD45 with CD4/TCR in a macromolec- association of CD45 with the TCR complex was dis-
rupted, while cells stimulated with the agonist peptideular complex on resting T cells.
In the present study, we can demonstrate a basal maintained CD45/TCR association. These data provide
additional evidence that association of CD45 with thebiochemical association of CD45 with the TCR complex
that is independent of CD4 expression and is regulated TCR may be an important regulatory mechanism before
and during T cell activation.in part by the ectodomain of CD45. The basal association
of CD45 with the TCR is also detected in resting, primary
CD41 T cells isolated from the peripheral lymphoid or- Results
gans of mice. As noted above, the experiments in CD45
transfected cell lines suggested that association of Biochemical Association of CD45 with TCR
Complex Is Independent of CD4CD45 with the TCR is correlated with enhanced T cell
activation and IL-2 production; thus, the regulation of We have previously shown that low molecular weight
isoforms of CD45 are associated with the CD4/T cellCD45 association with the TCR may be an important
control mechanism for modifying TCR-generated signal- receptor complex in fluorescence colocalization studies
and that this was regulated by the variable ectodomaining cascades during priming of naive T cells. In support
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of CD45 (Leitenberg et al., 1996). In order to determine
if this association was primarily dependent on CD4 or the
TCR, we performed similar fluorescence ªcocappingº
studies in which we assessed the ability of CD45 to
associate with CD4 in cells that lack CD3 and the ability
of CD45 to associate with CD3 in cells that do not ex-
press CD4. Figure 1 illustrates representative cocapping
data in which cells expressing CD45RO were induced to
cap using biotinylated anti-TCR or anti-CD4 antibodies
followed by avidin-PE, and the association of CD45 in
the cap was assessed using anti-CD45-FITC antibodies.
In Figure 1B, a summary of these data from three inde-
pendent experiments indicates no significant difference
in CD45RO association with the TCR in CD41 or CD42
clones. In contrast, when CD31 and CD32 clones of the
CD45RO transfectants were assessed for CD45 associa-
tion with CD4, there was a marked decrease in CD45/
CD4 association in the absence of CD3. These data
demonstrate that CD45 association with the CD4/TCR
complex seems to primarily depend on the presence of
the TCR since cells that do not express CD4 maintain
CD45RO association with CD3, while in the absence of
CD3 the association of CD45 with CD4 is diminished.
In order to confirm these findings and to determine if
CD45/TCR association was present on resting cells (in
the absence of TCR cross-linking to induce cap for-
mation), coimmunoprecipitation experiments were done
in which the TCR or CD4 was precipitated and the
presence of CD45 in the immunoprecipitate was as-
sessed by Western blotting. (Figure 2). In Figure 2A, the Figure 2. Coimmunoprecipitation of CD45 with the T Cell Receptor
TCR was precipitated in cells expressing CD45ABC or Complex
CD45RO with and without CD4. Regardless of whether (A) Lysates of 107 BW5147 cells expressing either CD45RO (RO) or
the cells express CD4, CD45 is readily detected follow- CD45ABC (A) or CD45-negative cells (-) were immunoprecipitated
with anti-TCR antibody (H57). After immunoprecipitation, the sam-ing TCR immunoprecipitation. Although both CD45RO
ples were split and either applied to an 8% nonreducing SDS-PAGEand CD45ABC are coimmunoprecipitated, it appears
and blotted with anti-CD45 or onto a 12% reducing gel and blottedthat more CD45RO is associated with the TCR than
with anti-z.CD45ABC even though there is a similar amount of TCR
(B) CD45RO1 cells were immunprecipitated with either anti-TCRb
z chain immunoprecipitated in each cell line, and each (H57) or anti-CD4 (GK1.5-coupled sepharose). After immunoprecipi-
cell line contains equivalent levels of CD45 by Western tation, the samples were split as above and either blotted for CD45
and CD4 after separation on an 8% nonreducing gel or z on a 12%Blot of cell lysate (see Figure 3) and by cell surface
reducing gel.expression (data not shown). Precipitation and blotting
specificity controls include CD45-negative cells and T
cell receptor±negative cells that express CD45. Neither CD45 (CD45RO) preferentially associate with the T cell
shows evidence for nonspecific bands or nonspecific receptor compared to higher molecular weight isoforms
association of CD45 during immunoprecipitation. Figure (CD45ABC). A more precise quantitation of the relative
2B demonstrates a similar experiment comparing the amounts of CD45RO versus CD45ABC associated with
ability of anti-TCR and anti-CD4 to coimmunoprecipitate the TCR following TCR immunoprecipitation was done
CD45. As in Figure 2A, CD45 is specifically coimmuno- by densitometric analysis by normalizing the amount of
precipitated with the T cell receptor but is not readily CD45 in the immunoprecipitate to the total amount of
detectable by Western blot following anti-CD4 precipita- CD45 in each cell line from a whole cell lysate detected
tion. In total, these data provide biochemical evidence in the same blot (Figure 3). Different dilutions of lysate
that there is a stable complex of CD45 and the TCR that and immunoprecipitate were used to ensure that the
is independent of the presence of CD4. In addition, this chemiluminescence signal in the Western blot had not
complex is present in the absence of prior T cell activa- plateaued, and a representative experiment is shown in
tion and is independent of CD4 or CD3 cross-linking that Figure 3A. In an average of three independent experi-
was necessary to induce capping in the fluorescence ments, there was approximately 3- to 4-fold more
colocalization experiments (Figure 1). CD45RO associated with the TCR compared to CD45ABC
(Figure 3B).
CD45 Isoform Regulation of Association
with the TCR Complex Organization of the CD45/TCR Complex
in Resting Primary CD41 T CellsSimilarly to the cocapping data (Figure 1; Leitenberg
et al., 1996), the immunoprecipitation experiments in The data presented above indicate the presence of a
preexisting complex of CD45 with the TCR in cell linesFigure 2 indicate that low molecular weight isoforms of
Immunity
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Figure 4. CD45 Association with the TCR Complex in Primary CD41
T Cells
CD41 T cells were purified by negative selection from spleen and
lymph nodes of 8-week-old mice. (A) 10 3 106 cells per group were
lysed and immunoprecipitated with 5 mg of either CD45, TCR, or
CD4 antibodies and then assessed for the presence of CD45 or lck
upon Western blot following separation by 7% nonreducing SDS-
PAGE. The arrows indicate the presence of CD45B and CD45RO
isoforms. (B) 20 3 106 cells were immunoprecipitated with either
anti-CD45 or TCRb, and the immune complexes were serially diluted
1:2 and analyzed for the presence of CD45 on a 7% nonreducing
gel or TCRa and TCRz on a 12% reducing gel. The asterisk indicatesFigure 3. Quantification of CD45RO versus CD45ABC Coimmuno-
the presence of an intact antibody band shadow that is sometimesprecipitated with the T Cell Receptor Complex
visible using the avidin-horseradish peroxidase conjugate to de-
The T cell receptor was immunoprecipitated with anti-TCR as above
velop the Western blot.
from 2 3 107 cells expressing CD45ABC or CD45RO. Whole cell
lysate from 106 cell equivalents was set aside prior to immunoprecip-
itation. (A) Different dilutions of immunoprecipitate or whole cell cells in the Western blots shown in the following experi-
lysate were separated on a 5% nonreducing gel and blotted with
ments was determined in comparison with a ladder ofanti-CD45. (B) The average and standard deviation of normalized
CD45 isoforms obtained from the CD45-transfected celldensitometric data from three independent immunoprecipitation ex-
lines described previously and by immunoprecipitationperiments is represented. The amount of CD45 immunoprecipitated
with the T cell receptor was normalized to the amount of CD45 in with CD45B-specific antibodies (data not shown). As
the whole cell lysate from 2.5 3 105 cell equivalents for each cell line. shown in Figure 4A, both CD45B and CD45RO isoforms
are readily detected following TCR precipitation, and,
as in Figure 2, immunoprecipitation with anti-CD4 failed
to coprecipitate significant amounts of CD45. As showntransfected with individual CD45 isoforms and that this
correlates with enhanced T cell activation (Novak et al., in the bottom panel of Figure 4A, the same blot was
also examined for the presence of lck as a control for1994; Leitenberg et al., 1996). In order to confirm these
findings in primary CD41 T cells and to investigate the CD4 immunoprecipitation. Of note is the significant
amount of lck found coimmunoprecipitated with CD45stoichiometry of CD45/TCR association in cells that ex-
press wild-type levels of CD45, CD3/TCR, and CD4, in addition to the lck associated with CD4. In addition, a
small amount of lck is also found coimmunoprecipitatedsimilar coimmunoprecipitation experiments were per-
formed using purified CD41 T cells from the spleen and with CD3/TCR.
In order to determine the relative percent of CD45lymph node of cytochrome C±specific T cell receptor
transgenic mice. In the mouse, naive CD4 T cells pre- associated with the TCR and the amount of TCR associ-
ated with CD45, a semiquantitative immunoprecipitationdominantly express a mixture of two isoforms of CD45:
CD45B (variable exon 5 only expressed) and CD45RO experiment was performed (Figure 4B). Lysates from
primary CD41 T cells were immunopreciptated with anti-(variable exon 4, 5, and 6 not expressed) (Rogers et al.,
1992). The identity of these isoforms in primary CD41 bodies to the TCR or CD45. Serial 2-fold dilutions of
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the resulting immunoprecipitate were then analyzed by
Western blot to compare the total amount of TCRa or
TCRz with the amount associated with CD45. The con-
verse experiment is also shown in which the total
amount of CD45 is compared to the amount coimmuno-
precipitated with the TCR complex. In both cases, signif-
icant association between CD45 and the TCR complex
are detected, and CD45 immunoprecipitation coimmu-
noprecipitates similar levels of both TCRa and the z
chain. Comparisons between the dilutions of the total
amount of CD45 and TCR to the amounts of coprecipi-
tated CD45 and the TCR present in a complex suggest
that approximately 10%±30% of the TCR and CD45 are
coassociated.
Differential Regulation of CD45/TCR Association
following T Cell Activation with Agonist
or Altered Peptide Ligands
The above data demonstrate the presence of a basal
complex of CD45 with the TCR in resting primary CD41
T cells. Our previous experiments correlating antigen
responsiveness with CD45/TCR association predict that
this association is required to initiate and maintain effi-
cient signal transduction in naive T cells and that disrup-
tion of CD45/TCR association would result in diminished
T cell activation. Previous work from our laboratory has
characterized the pattern of early signaling events in
naive T cells following stimulation with an agonist and
partial agonist peptide of moth cytochrome C. In this
system, stimulation with the agonist peptide results in
a sustained pattern of early signaling events (Ca21 mobi-
lization, z phosphosphorylation), while stimulation with
a partial agonist peptide induces a diminished and tran-
sient pattern of early signaling events (Boutin et al.,
1997). We hypothesized that during stimulation with the
partial agonist peptide, CD45/TCR association may be
disrupted, resulting in a diminished or abbreviated sig-
naling cascade. This hypothesis was tested by immuno-
Figure 5. Differential Regulation of CD45/TCR Association duringprecipitating the TCR complex following stimulation of
Agonist and Partial-Agonist Stimulationnaive MCC-specific CD4 T cells with agonist peptide
(A) CD41 T cells (20 3 106) were purified from MCC-specific TCR(pMCC) or partial agonist peptide-pulsed antigen-pre-
transgenic mice and stimulated for 5 min with APC pulsed with 20senting cells and examining the immunoprecipitate for
mM of either pMCC (agonist), K99R (partial agonist), or pBSA (controlCD45. As shown in Figure 5A, TCR/CD45 association is
peptide). The cells were then assessed for CD45/TCR association
modestly enhanced following stimulation with agonist following TCRb immunoprecipitation and separation by nonreduc-
peptide (compared to stimulation with a control I-E bind- ing 7% SDS-PAGE as described in Figure 4. The middle panel is a
ing peptide, pBSA, which does not interact with the blot for TCRa/b from the same gel to control for equal amounts of
MCC-specific TCR) but is substantially diminished after immunoprecipitated TCR in each lane, and the bottom panel shows
equivalent amounts of immunoprecipitated TCR z chain are alsostimulation with the partial agonist, K99R. In all cases,
present from 20% of the sample separated on a 12% reducing gel.equal amounts of TCR were immunoprecipitated, as
(B) The average change in TCR-associated CD45RO following stimu-shown by Western blot for TCR a/b and TCR-associated
lation with the pMCC or K99R peptides compared to baseline levels
z chain. Average densitometric quantitation of these re- seen with control peptide (pBSA). The amount of CD45 coimmuno-
sults from four independent experiments indicates a precipitated with the TCR was assessed by densitometric scanning
consistent 40%±60% loss of CD45/TCR association fol- and normalized to the amount of TCR a/b from the same gel for
each sample. The data shown are the average and standard devia-lowing stimulation with the partial agonist peptide com-
tion from four independent experiments.pared to unstimulated controls, while CD45/TCR associ-
(C) Purified CD41 T cells were stimulated with APC only (-) or APCation is maintained and enhanced following agonist
pulsed with either pMCC or K99R for the indicated periods of timepeptide stimulation (Figure 5B). In order to examine the
and then assessed for CD45/TCR association as in (A). Control lanes
kinetics of CD45/TCR dissociation, a similar experiment marked APC contain APC only and are immunoprecipitated with
was performed in which the TCR complex was immuno- anti-TCRb, and control lane C contains APC and T cells and is
precipitated at various time points following peptide immunoprecipitated with a control antibody (anti-CD8). As in Figure
4, the asterisk indicates the presence of the antibody band.stimulation. As shown in Figure 5C, CD45 dissociation
from the TCR occurs approximately 5 min after partial
agonist stimulation, while CD45/TCR association is sta-
bly maintained following agonist peptide stimulation for
Immunity
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Figure 6. CD4 Cytoplasmic Tail Is Required
to Maintain CD45/TCR Stimulation following
Stimulation with Agonist Peptide
(A) Purified CD41,CD82 T cells from CD4 wild-
type and CD4 d cyt mice were immunoprecip-
itated with anti-TCRb, anti-CD45, and anti-
CD4 as described in Figure 4. The presence of
associated CD45, lck, and TCR components
was detected by Western blot as described
in Figure 4.
(B) Purified CD41,CD82 T cells from CD4 wild-
type and CD4 d cyt mice were stimulated with
APC pulsed with the control peptide (pBSA)
or agonist peptide (pMCC) for 5 min as de-
scribed in Figure 5. The cells were lysed and
assessed for the presence of coimmuno-
precipitated TCR and CD45 as described in
Figure 4.
(C) Average densitometric data of CD45RO
coimmunoprecipitated with the TCR follow-
ing agonist peptide stimulation in T cells from
CD4 wild-type or CD4 d cyt mice. The amount
of CD45RO is normalized to the amount of
TCR a/b found in the same sample as de-
scribed in Figure 5. The results are the aver-
age of three independent experiments.
at least 15 min. These data suggest that variant peptide transgene. As expected, cells expressing the dcyt CD4
transgene did not have CD4-associated lck and alsosignaling can alter the composition of the TCR complex,
promoting the dissociation of CD45, which in turn may lost TCR-associated lck indicating the requirement for
CD4-lck interaction in order to detect lck associationdownmodulate TCR signaling causing a transient signal-
ing phenotype. Alternatively, the incomplete signaling with the TCR in resting T cells. Interestingly, this is in
contrast to the association of lck with CD45, which wascascade induced by the partial agonist peptide may
result in the destabilization of the CD45/TCR complex. only modestly affected in cells expressing the mutant
CD4 transgene. This is in agreement with previous data
in cell lines in which detection of CD45-associated lckCD4 Cytoplasmic Tail Is Required for Maintaining
CD45/TCR Association following Agonist was independent of the presence of CD4 (Ross et al.,
1994). As shown in Western blots of the whole cell ly-Peptide Stimulation
As indicated above, we have shown that TCR/CD45 sates, there are equal levels of CD45, TCR, and lck from
wild-type CD4 T cells or CD4 d cyt T cells. Of note isassociation does not require the expression of CD4.
However, CD4 signaling may be involved in maintaining the consistent finding shown in Figures 6A and 6B that
CD45/TCR association is modestly enhanced in T cellsthe stability of this interaction following T cell stimula-
tion. Since partial agonist signaling has been associated from the CD4 dcyt mice. This may indicate that some
CD45 is sequestered from the TCR complex in CD41with failure to recruit CD4 to the TCR complex (Madrenas
et al., 1997), we hypothesized that CD4/TCR association cells.
When MCC-specific T cells from the CD4 dcyt micemay be required to maintain the CD45/TCR association
seen after agonist peptide signaling. In order to investi- were stimulated with agonist peptide (pMCC), CD45/
TCR association was diminished (Figures 6B and 6C).gate this possibility, MCC-specific TCR transgenic T
cells from wild-type mice or CD4 knockout mice recon- Figure 6C shows average densitometry data from three
independent experiments indicating that in the absencestituted with a CD4 transgene encoding for the trans-
membrane and ectodomain of CD4 (CD4 d cyt) were of the cytoplasmic tail of CD4 agonist peptide destabi-
lizes the CD45/TCR complex. This is in contrast to thestimulated with agonist peptide as described in Figure 5.
Prior to this experiment, it was important to confirm results obtained with cells expressing wild-type CD4 in
which CD45/TCR association is augmented followingin resting, primary CD4 T cells that the association of
CD45 with the TCR was independent of CD4. When stimulation with agonist peptide and only is diminished
following stimulation with the partial agonist peptide,purified CD82 T cells are isolated from CD4-deficient
mice (data not shown) or CD4-deficient mice reconstitu- K99R. These data suggest that CD4-associated lck may
be necessary to maintain the association of CD45 withted with a mutant CD4 transgene that does not encode
for the cytoplasmic tail of CD4 (CD4dcyt), CD45 associa- the TCR following peptide stimulation.
If lck was important in stabilizing the TCR/CD45 asso-tion with the TCR complex is not diminished (Figure 6A).
Also in agreement with Figures 2B and 4A, immunopre- ciation, we hypothesized that TCR-associated lck would
be differentially regulated by agonist and variant peptidecipitation with CD4 antibodies fails to efficiently coim-
munoprecipitate CD45 in primary, resting CD41 T cells. signaling. To test this prediction, we examined the sta-
bility of the TCR/lck association following agonist orAs a control for these experiments, the ability to copre-
cipitate lck with CD4, CD45, and the TCR was also exam- altered peptide ligand stimulation (Figures 7A and 7B).
In these experiments, cells were stimulated with theined in cells expressing wild-type CD4 or the CD4dcyt
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lck from these cells (bottom panel of Figure 7A) shows
that both the agonist and K99R peptides induce a similar
level of serine/threonine phosphorylation as shown by
the peptide-specific induction of a slower mobility form
of lck (p60). Densitometric analysis from four indepen-
dent experiments is shown in Figure 7B, indicating that
CD45/lck association is diminished by approximately
50% following K99R stimulation. These data indicate
that in addition to CD45, the basal association of lck
with the TCR complex is differentially regulated by pep-
tides of different avidities for the TCR. The dissociation
of lck and CD45 from the TCR in these experiments also
correlates with different patterns of z tyrosine phosphor-
ylation (Figure 7A, second panel). Consistent with our
previously published data pMCC induces phosphoryla-
tion of a saturated form of phosphoz (p23), in contrast
to the altered peptide K99R that primarily induces p21 z
phosphorylation (Boutin et al., 1997). These experiments
suggest that in addition to the different patterns of tyro-
sine phosphorylation induced by agonist and altered
peptide ligands there is a change in the macromolecular
composition of the TCR signaling complex.
Discussion
In the present report, we provide evidence that the trans-
membrane tyrosine phosphatase CD45 is basally asso-
ciated with the CD3/TCR complex and that this associa-
tion is correllated with enhanced T cell activation. One
possible model for how CD45 association with the TCR
enhances TCR signaling pathways would be by increas-
ing lck activity upon recruitment to the TCR complex
following recognition of antigen. This in turn would pro-
mote full phosphorylation of the ITAM motifs of the
CD3/z components and facilitate the recruitment and
activation of the ZAP70 tyrosine kinase. In addition,
CD45 may maintain lck in an ªopenº configuration pro-
Figure 7. Differential Regulation of TCR-Associated lck by Agonist moting lck interaction and recruitment of a variety of
and Altered Peptide Ligand Stimulation adapter proteins and other signaling molecules into a
(A) Purified CD41,CD82 T cells from MCC-specific TCR transgenic large macromolecular complex that further facilitates T
mice were stimulated with APC pulsed with 20 mM of the control
cell activation and IL-2 production independently of lckpeptide (pBSA), agonist peptide (pMCC), or altered peptide ligand
kinase activity (Collins and Burakoff, 1993; Sieh et al.,(K99R) for 5 min as described in Figure 5. The cells were lysed and
1993; Xu and Littman, 1993). Thus, the presence of CD45assessed for the presence of coimmunoprecipitated TCR and lck
as described in Figures 4 and 5. The bottom panel is a Western blot in a preformed complex with the TCR would precommit
of total lck from whole cell lysates from 5 3 105 cells separated by the T cell to respond optimally when exposed to src
a nonreducing 7% SDS-PAGE. Phosphorylated z chain was immu- family kinases, while the absence of CD45 from the TCR
noprecipitated with anti-TCRb from lysates from the same experi-
complex would precommit that cell to respond subopti-ment and detected with anti-phosphotyrosine monoclonal antibody
mally or alternatively through src family kinase-indepen-after separation by 12% SDS-PAGE (second panel). The same blot
was stripped and reprobed for total z protein (third panel). dent signaling pathways.
(B) Average densitometric data of lck coimmunoprecipitated with We currently know very little regarding the biochemi-
the TCR following peptide stimulation in T cells from four indepen- cal basis for the basal association of CD45 with the TCR.
dent experiments. The data are normalized to the amount of TCR It is clear from coimmunoprecipitation experiments and
a/b for each sample as described in Figure 5.
fluorescence colocalization data that the ectodomain of
CD45 can regulate the efficiency of association with the
TCR in that high molecular weight CD45 isoforms do notindicated peptides and the TCR immunoprecipitated
associate well with the TCR compared to low molecularand the presence of associated lck was detected by
weight CD45 isoforms. Since the high molecular weightWestern blot. Indeed, similarly to CD45/TCR associa-
CD45 isoforms contain the same base peptide sequencetion, we found that stimulation with the partial agonist
as the low molecular weight isoforms, it seems likely thatpeptide, K99R, disrupted the basal association of lck
the failure of the high molecular weight CD45 isoformswith the TCR. This was in contrast to stimulation with
to associate with the TCR is due to steric and staticthe agonist peptide in which TCR/lck association is
maintained. Interestingly, Western blot analysis of total interference from the additional protein encoded in the
Immunity
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variable exons and due to the extensive additional glyco- apparent contradiction to the topological model of T cell
activation proposed by Shaw and Dustin (1997), whosylation. Electron microscopic imaging of purified solu-
ble CD45 ectodomains reveals that the CD45ABC iso- theorized that molecules like CD45 that extend greater
than 15±20 nm from the cell surface would be excludedform exhibits an extended rodlike structure and is
predicted to extend 61 nm above the cell surface com- from the TCR/APC contact zone. This model assumes
that CD45 extends perpendicularly from the cell surface.pared to the CD45RO isoforms, which are predicted to
extend approximately 28 nm (McCall et al., 1992). This It is possible that CD45 (especially smaller isoforms of
CD45) are sufficiently bent laterally to allow for inclusionextra length of the CD45ABC isoform may simply pre-
vent a default association that occurs more readily with in the APC/TCR contact region. In agreement with our
observations of sustained CD45/TCR association fol-the low molecular weight CD45RO isoform. The large
size and heavily glycosylated nature of CD45 has been lowing agonist peptide stimulation are fluorescent im-
aging studies from Sperling et al. (1998) and Kupferpredicted on theoretical grounds to be an impediment
to T cell activation by sterically interfering with APC and colleagues (A. Kupfer, personal communication),
demonstrating the presence of CD45 in the TCR/APCinteraction (Shaw and Dustin, 1997). Our data suggest
that in addition to the difficulties postulated to occur due contact zone cap. Thus, it appears that despite the theo-
retical constraints of the large size of CD45, it is ableto expression of high molecular weight CD45 isoforms
during TCR-APC contact, there is also a difference in to cluster with the TCR during APC contact following
stimulation with a strong agonist peptide.lateral association of CD45/TCR secondary to the size of
the CD45 isoform. Thus, cells that express low molecular Although it is clear from our previously published data
that there is a different pattern of tyrosine phosphoryla-weight CD45 isoforms have the dual advantage of less
interference during TCR/APC contact and a TCR signal- tion following agonist or APL stimulation (Boutin et al.,
1997), we do not have sufficient data to conclude thating complex poised to respond with higher efficiency.
It should be noted that although it is clear that the this is directly due to failure of CD45 to stably associate
with the TCR. In fact, we have reason to believe that aectodomain of CD45 can regulate association with the
TCR, it remains uncertain if the cytoplasmic or trans- transient signaling pattern does not always correllate
with lack of stable CD45/TCR association. Using T cellsmembrane domains of CD45 are also involved in pro-
moting and stabilizing this interaction with the T cell isolated from CD4 mutant mice, we have previously
found that stimulation with a strong agonist peptidereceptor complex. This seems quite likely in view of
CD45 interaction with lck that may act as a bridge with induces a sustained signaling pattern (Leitenberg et al.,
1998). However, in the data shown in Figure 6, CD45/other components of the TCR signaling complex. Simi-
larly to CD45/TCR association, CD45/lck association oc- TCR association is destabilized in this situation. This
suggests that in the presence of a sufficiently strongcurs independently of the expression of CD4, and the
precise mechanism for this association remains uncer- TCR signal, a sustained signaling pattern can be main-
tained in the absence of CD45/TCR association. This istain. One possibility is that it is mediated by an adapter
protein known as CD45-associated protein (CD45-AP), similar to other data from our lab using CD45 transfected
cell lines in which we were able to stimulate cells thatwhich requires the transmembrane domain of CD45 for
detection in coimmunoprecipitation experiments (McFar- expressed high or low molecular weight CD45 isoforms
equally well following stimulation with immobilized anti-land and Thomas, 1995). In the absence of CD45-AP,
CD45-lck association is partially diminished but remains CD3 and only saw CD45-specific affects following stim-
ulation with a weaker signal such as peptide. We sug-detectable, suggesting that both the transmembrane
and the cytoplasmic domain of CD45 may be involved in gest that the presence of CD45 with the TCR complex
can act to facilitate T cell activation following modestmediating association with lck (McFarland and Thomas,
1995; Matsuda et al., 1998). This may be an important or weak signals to the TCR but that CD45 association
with the TCR is not required during strong signaling.mechanism for stabilizing and regulating CD45/TCR as-
sociation as discussed below. The mechanism for how CD45 is dissociated from this
complex remains unclear but may be a byproduct ofRegardless of the mechanism of CD45/TCR associa-
tion, it seems likely, however, that control of this associ- the incomplete activation program induced by partial
agonist peptides and failure to form a stable complexation will be an important regulatory point before and
during T cell activation. In the present manuscript, we with CD4-associated lck. For example, incomplete
phosphorylation of the CD3/z ITAM motifs may preventprovide evidence that CD45/TCR association is differen-
tially regulated by agonist and partial agonist signaling CD4-lck from stably associating with the TCR via SH2
domain-dependent interactions that may also stabilizeof resting, primary CD41 T cells. Using a well character-
ized model system for naive T cell activation by agonist CD45-TCR association since CD45 also can associate
with lck. This additional stabilization of CD45 with theand partial agonist peptides (which induce sustained or
transient activation patterns respectively), we show that TCR complex may be necessary since TCR ligation has
recently been shown to induce partitioning into lipidstimulation with the partial agonist peptide promotes
dissociation of CD45 from the TCR complex within 5 enriched membrane microdomains following activation
(ªraftsº) (Montixi et al., 1998; Xavier et al., 1998; Zhangmin after activation. This roughly correlates with the time
course of dephosphorylation of the saturated isoform et al., 1998). CD45 is thought to be largely naturally
excluded from these domains (Rodgers and Rose, 1996;of phosphoz and with the duration of calcium transients
generated by the partial agonist (Boutin et al., 1997). In Xavier et al., 1998). In addition to components of the
TCR complex partioning into distinct membrane micro-contrast, following stimulation with the agonist peptide,
CD45/TCR association remains relatively stable for at domains, TCR signaling may also differentially affect
cytoskeletal associations of the TCR, CD4, and CD45least 15 min following stimulation. These data are in
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by labeling with either biotinylated anti-CD4 (GK1.5) or clonotypicthat could also disrupt basal associations present in
anti-TCR (3D3). The cells were then washed and labeled with fluores-resting T cells. Thus, in order to promote sustained asso-
cein conjugated pan-specific anti-CD45 (PharMingen). Control cellsciation with the TCR, additional activation-dependent
(labeled with PE or FITC alone) were always prepared simultaneously
interactions may be required to stablize CD45 associa- for each cell line to set compensation parameters. Fluorescence
tion with the TCR/CD4/lck complex. localization was determined using a scanning video laser cytometer
(ACAS 570, Meridien Instruments) equipped with a 200 mW argonOur data examining CD45/TCR association following
laser. For each experimental group, 100 capped cells were counted,activation in T cells expressing mutant CD4 that cannot
and the percent of capped cells with associated CD45 was deter-associate with lck suggest that the presence of lck in the
mined.TCR complex is critical to stabilize CD45 association. In
these experiments, CD45/TCR association was dimin-
Peptides
ished following stimulation with the agonist peptide sim- Moth cytochrome c (81±103): pMCC, VFAGLKKANERADLIAYLKQ
ilarly to that seen following stimulation with the partial ATK; K99R, VFAGLKKANERADLIAYLRQATK; and pBSA (141±154),
GKYLYEIARRHPYF peptides were synthesized by the W. M. Keckagonist peptide. This is in contrast to the increase in
Foundation Biotechnology Resource Laboratory. All peptides wereCD45/TCR association seen following agonist peptide
high-pressure liquid chromatography purified prior to use.stimulation in cells expressing wild-type CD4. These
data indicate that the cytoplasmic tail of CD4 and poten-
Preparation of APC and CD41 T Cells
tially CD4-associated lck are required to stabilize the T cell depleted APC were prepared by antibody-mediated comple-
interaction of CD45 with the TCR complex following ment lysis of 5R splenocytes as previously described (Leitenberg
activation. Consistent with this idea is our observation et al., 1998). CD41,CD82 T cells from lymph nodes and spleens
of transgenic mice were isolated using immunomagnetic negativethat the basal TCR/lck association, in addition to CD45,
selection as previously described (Leitenberg et al., 1998) usingis also diminished following stimulation with an altered
antibodies against CD8, CD32/CD16, B220, and MHC class II fol-peptide ligand. In summary, our data demonstrate a
lowed by incubation with anti-mouse and -rat Ig-coated magnetic
basal association of CD45 with the TCR complex prior beads (Perspective Diagnostics). Purity of the recovered Va111,
to T cell activation and indicate that regulation of this CD41 T cells (or Va111, CD42CD82 T cells in CD42/2 mice) was
association before and during T cell activation may be usually 85%±95% as determined by staining with anti-CD4 and anti-
Va11 mAb.a mechanism to differentially affect T cell signaling
pathways.
T Cell Activation
T-depleted splenocytes from B10.A (5R) mice were pulsed with 20Experimental Procedures
mM of the indicated peptide for 2±4 hr at 378C in Hank's balanced salt
solution supplemented with 5% FCS. The pulsed antigen-presentingAntibodies
cells were washed once and mixed 1:1 with purifed MCC-specificThe following monoclonal antibodies were used in this study: M1/
T cells in microcentrifuge tubes, quickly pelleted, and incubated at9.3.4. HL.2, pan-specific anti-CD45 (TIB122, ATCC), anti-CD4
378C for the indicated times and then lysed in ice-cold lysis buffer.(GK1.5), anti-TCRb (H57), and an anti-clonotypic antibody for the
D10 TCR (3D3) (Kaye et al., 1983). All antibodies were purified from
Immunoprecipitation and Western Blottingculture supernatants on protein G columns and dialyzed against
Coimmunoprecipitation of CD45 with CD3/TCR was done using aPBS before use. For some experiments, purified anti-TCRb (H57),
1% Brij 96/97 (Sigma) lysis buffer (20 mM Tris-Cl [pH 7.5], 150 mManti-TCRa (H28), anti-CD45 (30-F11), and anti-CD4 (GK1.5) were
NaCl, 1 mM MgCl2, and 1 mM EGTA) supplemented with proteasepurchased from PharMingen.
and phosphatase inhibitors (10 mg/ml leupeptin, 10 mg/ml aprotinin,
1 mM PMSF,1 mM Na3VO4, and 50 mM NaF). Cells were lysed forCell Lines
30 min on ice and the detergent soluble material separated by cen-A CD45-negative mutant of the BW5147 AKR thymoma was trans-
trifugation for 15 min at approximately 14,000 3 g. Immunoprecipita-fected with individual CD45 isoform cDNAs encoding CD45RO and
tion was done using 5 mg of the indicated monoclonal antibodyCD45ABC as described previously (Novak et al., 1994). These cells
followed by Protein G sepharose (Pharmacia Biotech, Uppsala, Swe-have also been transfected with CD4 and the T cell receptor from
den) for an additional 1 hr. In some experiments, directly conjugatedthe D10.G4.1 Th2 cell clone. T cell receptor±negative revertants of
GK1.5-sepharose was used to immunoprecipitate CD4.CD45ABC and CD45RO clones were generated by repetitive cell
Standard Western blot analysis was done following SDS poly-sorting using a FACStar flow cytometer. All cell lines were routinely
acrylamide electrophoresis and transfer onto nitrocellulose papermonitored by flow cytometry to ensure stable expression of CD45,
(Schleicher and Schuell, Keene, NH). CD45 was detected using aCD4, and CD3. When necessary, the cells are sorted so that the
biotinylated anti-CD45 antibody (M1/9.3.4. HL.2 or 30-F11) that isdifferent clones maintain similar expression levels of the transfected
pan-specific for all isoforms followed by avidin-coupled horseradishgenes.
peroxidase. The z chain of the T cell receptor and lck were detected
using rabbit polyclonal antisera prepared in our laboratory (BoutinMice
et al., 1997) followed by protein A coupled horseradish peroxidaseB10.A (5R) (5R) mice were obtained from The Jackson Laboratory.
(Sigma). TCRa was detected with the H28 monoclonal antibodyThe AND TCR transgenic mice in which CD41 T cells express a TCR
(PharMingen). CD4 was detected using biotinylated anti-CD4specific for the carboxyl terminus of pigeon cytochrome c have
(GK1.5). Determination of phosphorylated z induction was done fol-been previously described (Kaye et al., 1989) and are bred in our
lowing H57 immunoprecipitation as described above except 1%facilities and maintained as heterozygotes on B10.BR background.
NP-40 is used in the lysis buffer and the 4G10 anti-phosphotyrosineThe CD42/2 and CD42/2 d cyt mice were generously provided by D.
monoclonal antibody (UBI) was used in the Western blot. All ofLittman (New York University) and were backcrossed 5±6 times onto
the immunoblots were developed with the ECL chemiluminescenta B10.BR background and crossed with the AND T cell receptor
detection system.transgenic mice (Leitenberg et al., 1998). All mice used in these
studies were 6 to 10 weeks old.
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